IL-6 inhibitor

Times Union: St. Peter’s Seeking Plasma Donations from Recovered COVID-19 Patients

April 10, 2020

The Times Union did a story about how SPHP is among the first hospital systems nationwide to receive federal approval for an experimental COVID-19 treatment. [...]

St. Peter’s Health Partners Battling COVID-19 with Groundbreaking Therapies, Interdisciplinary Care

April 10, 2020

Multiple groundbreaking therapies to treat the sickest COVID-positive patients in the Capital Region are being employed at St. Peter's Health Partners' (SPHP) acute care hospitals in Albany and Troy. They include the antiviral drug remdesivir; IL-6 inhibitor drugs; macrophage inhibitors; and convalescent blood plasma therapy. [...]